R. Komaki

1.5k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

R. Komaki is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, R. Komaki has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 4 papers in Oncology. Recurrent topics in R. Komaki's work include Lung Cancer Diagnosis and Treatment (11 papers), Advanced Radiotherapy Techniques (6 papers) and Lung Cancer Treatments and Mutations (6 papers). R. Komaki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Advanced Radiotherapy Techniques (6 papers) and Lung Cancer Treatments and Mutations (6 papers). R. Komaki collaborates with scholars based in United States, France and United Kingdom. R. Komaki's co-authors include W. K. Hong, Hari M. Dhingra, Jack A. Roth, J. S. Lee, Joe B. Putnam, Frank V. Fossella, E. Neely Atkinson, Malcolm H. McGavran, Michael Ryan and Martin Chasen and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and Medical Physics.

In The Last Decade

R. Komaki

16 papers receiving 1.1k citations

Hit Papers

A Randomized Trial Comparing Perioperative Chemotherapy a... 1994 2026 2004 2015 1994 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Komaki United States 8 1.0k 412 197 188 119 16 1.1k
Ljubiša Aćimović Serbia 15 963 1.0× 793 1.9× 315 1.6× 125 0.7× 195 1.6× 31 1.4k
B. Emami United States 13 817 0.8× 357 0.9× 242 1.2× 263 1.4× 90 0.8× 36 1.1k
Slobodan Milisavljević Serbia 18 1.0k 1.0× 880 2.1× 312 1.6× 139 0.7× 200 1.7× 47 1.5k
Makoto Shinoto Japan 14 537 0.5× 329 0.8× 316 1.6× 166 0.9× 197 1.7× 52 783
J. Knegjens Netherlands 12 599 0.6× 522 1.3× 247 1.3× 237 1.3× 113 0.9× 28 1.0k
Cristina Mantovani Italy 16 562 0.6× 141 0.3× 375 1.9× 249 1.3× 112 0.9× 32 800
D. Lerouge France 16 739 0.7× 540 1.3× 164 0.8× 271 1.4× 156 1.3× 48 1.1k
Julio Guerra Canada 6 832 0.8× 450 1.1× 175 0.9× 138 0.7× 71 0.6× 8 949
Naga Cheedella United States 7 656 0.6× 371 0.9× 153 0.8× 152 0.8× 242 2.0× 12 842
G. Kramer Netherlands 11 1.5k 1.5× 1.2k 2.8× 70 0.4× 153 0.8× 146 1.2× 23 1.8k

Countries citing papers authored by R. Komaki

Since Specialization
Citations

This map shows the geographic impact of R. Komaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Komaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Komaki more than expected).

Fields of papers citing papers by R. Komaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Komaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Komaki. The network helps show where R. Komaki may publish in the future.

Co-authorship network of co-authors of R. Komaki

This figure shows the co-authorship network connecting the top 25 collaborators of R. Komaki. A scholar is included among the top collaborators of R. Komaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Komaki. R. Komaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thor, Maria, Joseph O. Deasy, Chen Hu, et al.. (2018). The Role of Heart-Related Dose-Volume Metrics on Overall Survival in the RTOG 0617 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 102(3). S96–S96. 5 indexed citations
2.
Videtic, G.M., Rebecca Paulus, Wendy L. Parker, et al.. (2017). Long-Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients with Stage I Peripheral Non–small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S15–S16. 7 indexed citations
3.
Wang, Jing, B. Myles, JC Chang, et al.. (2013). Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Diseases of the Esophagus. 27(2). 168–175. 18 indexed citations
4.
Smith, Alfred R., Michael T. Gillin, Martin Bues, et al.. (2009). The M. D. Anderson proton therapy system. Medical Physics. 36(9Part1). 4068–4083. 143 indexed citations
5.
Britton, Keith R., George Starkschall, Hongtan Liu, et al.. (2007). SU-FF-J-104: Impact of Anatomical Changes On Dose Distributions During Three-Dimensional Radiotherapy (3D-CRT) of Lung Cancer: Preliminary Study Using Multiple 4-DCT. Medical Physics. 34(6Part6). 2392–2392. 1 indexed citations
6.
Swisher, Stephen G., R. Komaki, Jaffer A. Ajani, et al.. (2007). A Phase II Study of a Paclitaxel Based Chemoradiation Regimen With Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. International Journal of Radiation Oncology*Biology*Physics. 69(3). S106–S106. 4 indexed citations
7.
Fang, Lekun, R. Komaki, Pamela K. Allen, et al.. (2005). Comparison of Outcomes for Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer Treated with Two-Dimensional Versus Three-Dimensional Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 63. S227–S227. 1 indexed citations
8.
Arriagada, R., R. Komaki, & James D. Cox. (2004). Radiation dose escalation in non-small cell carcinoma of the lung. Seminars in Radiation Oncology. 14(4). 287–291. 14 indexed citations
9.
Komaki, R.. (2004). Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non?small-cell lung cancer: report of a randomized comparative trial*1. International Journal of Radiation Oncology*Biology*Physics. 58(5). 1369–1377. 8 indexed citations
10.
Komaki, R.. (2003). Combined treatment for limited small cell lung cancer. Seminars in Oncology. 30(4 Suppl 9). 56–70. 10 indexed citations
11.
Komaki, R., Pamela K. Allen, Zhongxing Liao, et al.. (2002). Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: Preliminary results. Seminars in Radiation Oncology. 12(1). 46–49. 66 indexed citations
12.
Grigsby, Perry W., R. Komaki, Patricia J. Eifel, et al.. (2001). Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology*Biology*Physics. 51(3). 62–62. 1 indexed citations
13.
Komaki, R.. (2000). Management of limited small-cell lung cancer. International Journal of Clinical Oncology. 5(4). 205–216. 1 indexed citations
14.
Cox, James D., William T. Sause, Roger W. Byhardt, et al.. (1994). Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies. Lung Cancer. 10. S161–S166. 7 indexed citations
15.
Roth, Jack A., Frank V. Fossella, R. Komaki, et al.. (1994). A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 86(9). 673–680. 804 indexed citations breakdown →
16.
Holmes, E. Carmack, N M Bleehen, Thierry Le Chevalier, et al.. (1991). Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report. Lung Cancer. 7(1-2). 11–13. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026